This page has been archived on the Web
Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.
Evra (2014-02-27)
- Starting date:
- March 3, 2014
- Posting date:
- March 10, 2014
- Type of communication:
- Drug Recall
- Subcategory:
- Drugs
- Hazard classification:
- Type I and II
- Source of recall:
- Health Canada
- Issue:
- Product Safety
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-38181
Recalled products
- Evra
Reason
This product may have been exposed to temperatures outside of the recommended storage requirements. The safety and efficacy of these drugs may be impacted by the temperature excursion.
Note: only the units shipped from Canadadrugs.com to the pharmacy in British Columbia, Canada are affected, not the entire lots.
Depth of distribution
Distributed to a pharmacy located in British Columbia, Canada and further distributed to end user in the United States.
Affected products
A. Evra
DIN, NPN, DIN-HIM
DIN 02248297
Dosage form
Patch
Strength
- Ethinyl estadiol, 0.60 mg
- Norelgestromin, 6 mg
Lot or serial number
- CKZT900
- CIZS400
Companies
- Recalling Firm
-
CanadaDrugs.com LP
10 Terracon Place
Winnipeg
R2J 4G7
Manitoba
CANADA
- Marketing Authorization Holder
-
Janssen Inc
19 Green Belt Drive
Toronto
M3C 1L9
Ontario
CANADA